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Letters to the Editoranticoagulation with mechanical
valve replacement, should be balanced
against the risk of proximal reopera-
tion during follow-up. Regarding
the published experiences of centers
favoring aortic root preservation in
the setting of acute type A dissection,
it has been our institution’s policy to
consider more definitive aortic root
repair for patients presenting with
dissection of all sinuses, an aortic
root diameter>47 mm, or dissection
extending to the iliac arteries.2-4
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To the Editor:
Currently, invasive mechanical
ventilation (IMV) in patients with
fibrosing interstitial pneumonia is a
devastating situation in the intensive
care unit (ICU). After 2 decades, the
prognosis is still poor.
Gaudry and colleagues,1 in an orig-
inal retrospective multicenter French
study, describe short- and long-termThe Journaloutcomes in critically patients with
fibrotic lung diseases undergoing
IMV. In their view, more frequent use
of lung protective strategies may influ-
ence poor outcomes, and individual
evaluation case-by-case evaluation is
needed for appropriate discrimination
of ICU patients. Their arguments are
solid, rational, and comprehensive
for current practice and across all
published studies, although major
drawbacks of this study were its retro-
spective design and limited number of
patients, Obviously, the recommenda-
tions are reasonable and appropriate;
however, some points need to be taken
into account:
First, the authors did not describe
reasons for underuse of lower-level
aggressive ventilation alternatives
before IMV in these populations.
Were the use of noninvasive ventila-
tion and criteria for IMV in this study
reflected properly? Recently, new
and promising observations have
emerged: (1) Although there is still
only a small number of studies, early
use of noninvasive ventilation in
selected patients may avoid IMV and
improve clinical conditions at ICU
admission.2 (2) Nasal high-flow cannu-
lation may improve oxygenation in
concert with low positive end-
expiratorypressure in selectedpatients.
Some patients with pulmonary fibrosis
have been treated under expanded indi-
cations for nasal high-flow cannulation
with promising results.3
Second, it is interesting that patients
who met criteria for lung transplant
and were breathing spontaneously
with noninvasive ventilation have
shown the best outcome as bridge to
lung transplant and adequate results
after bilateral lung transplant.4 These
are promising alternatives to IMV for
selected patients.2-4
Third, lung-protective ventilation
arguably provides the best hope for
good results of IMV in these patients.
It is a reasonable hope; however, lung
damage is currently equally associ-
ated with high levels of inspiratory
oxygenation fraction and low tidalof Thoracic and Cardiovascular Surgervolume with high or normal positive
end-expiratory pressure.5 Although
large, prospective studies are nonexis-
tent, it is a promising avenue.
Finally, it would be interesting to
know details regarding survivors that
are lacking in these studies, such as
measurements of health-related qual-
ity of life, and the influence of specific
natural history, such as rates of hospi-
tal admission and exacerbations after
ICU discharge and impact of early
pulmonary rehabilitative programs.
Further large international database
studies will illuminate solid bases to
define risk factors and prognosis in
these directions.
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j.jtcvs.2013.09.077Reply to the Editor:
We thank Dr Esquinas for his com-
ments and interest in our work.1 First,
we would like to underline that our
goal was not to promote invasive me-
chanical ventilation (IMV) for patients
with end-stage fibrosing interstitial
pneumonia but rather to provide an
update on their prognosis. Obviously,y c Volume 147, Number 3 1113
